폴리클로널 항체 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 용도별, 원료별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Polyclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Source, By End user, By Region and Competition, 2020-2030F
상품코드:1886363
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 폴리클로널 항체 시장은 2024년 98억 4,000만 달러에서 2030년까지 143억 2,000만 달러로, CAGR 6.45%로 성장할 것으로 예측됩니다. 폴리클로널 항체는 다양한 B세포 계통에서 유래한 다양한 항체의 집합체이며, 단일 항원상의 여러 에피토프에 결합하는 능력이 특징입니다. 이러한 생물제제는 진단 검사, 과학 연구 및 특정 치료 용도에 널리 사용되고 있습니다. 폴리클로널 항체 세계 시장은 주로 만성질환 및 감염성 질환의 발생률 증가로 인해 첨단 진단 및 치료 툴에 대한 요구가 주요 촉진요인으로 작용하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
98억 4,000만 달러
시장 규모 : 2030년
143억 2,000만 달러
CAGR : 2025-2030년
6.45%
가장 빠르게 성장하는 부문
2차 항체
최대 시장
북미
주요 시장 성장 촉진요인
만성질환 및 감염성 질환 증가 추세는 세계 폴리클로널 항체 시장의 주요 촉진요인으로 작용하고 있습니다. 이러한 질병 부담이 증가함에 따라 효과적인 진단 툴와 치료적 개입이 필요하며, 다양한 항체 솔루션에 대한 지속적인 수요가 촉진되고 있습니다.
주요 시장 과제
배치 간 편차는 세계 폴리클로널 항체 시장 확대에 큰 걸림돌이 되고 있습니다. 다양한 B세포 기원에 따른 고유한 이질성으로 인해 제조 로트 간 제품 특성의 불일치가 발생합니다.
주요 시장 동향
재조합 기술을 활용하는 것은 생산의 일관성과 확장성에 대한 역사적 과제를 해결함으로써 세계 폴리클로널 항체 시장을 변화시키는 중요한 동향입니다. 이 접근법을 통해 항체를 보다 제어되고 재현성 있게 제조할 수 있으며, 기존 방법에서 얻은 폴리클로널 제제의 로트 간 변동성을 극복할 수 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 폴리클로널 항체 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(1차 항체, 2차 항체)
용도별(바이오메디컬 연구 진단, 진단)
원료별(토끼, 염소, 양, 마우스, 기타)
최종사용자별(제약·바이오테크놀러지 기업, 병원·진단 센터, 학술·조사기관)
지역별
기업별(2024)
시장 맵
제6장 북미의 폴리클로널 항체 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 폴리클로널 항체 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 폴리클로널 항체 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 폴리클로널 항체 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 폴리클로널 항체 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 폴리클로널 항체 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Thermo Fisher Scientific Inc
Merck KGAA
Abcam Plc
Proteogenex Inc
Proteintech Group, Inc
Bio-Rad Laboratories Inc
BPS Bioscience, Inc
R&D Systems, Inc
Agilent Technologies, Inc.
Cusabio Technology LLC
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Polyclonal Antibodies Market will grow from USD 9.84 Billion in 2024 to USD 14.32 Billion by 2030 at a 6.45% CAGR. Polyclonal antibodies are a heterogeneous collection of antibodies derived from various B-cell lineages, characterized by their ability to bind to multiple epitopes on a single antigen. These biologics are extensively utilized in diagnostic assays, scientific research, and specific therapeutic applications. The global market for polyclonal antibodies is primarily driven by the increasing incidence of chronic and infectious diseases, necessitating advanced diagnostic and treatment tools.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 9.84 Billion
Market Size 2030
USD 14.32 Billion
CAGR 2025-2030
6.45%
Fastest Growing Segment
Secondary Antibodies
Largest Market
North America
Key Market Drivers
The increasing prevalence of chronic and infectious diseases stands as a primary catalyst for the global polyclonal antibodies market. The escalating burden of these conditions necessitates effective diagnostic tools and therapeutic interventions, driving continuous demand for versatile antibody solutions. For example, according to the American Cancer Society, in 2025, 2,041,910 new cancer cases are projected to occur in the United States, highlighting the ongoing need for advanced biomedical research and development in disease management.
Key Market Challenges
Batch-to-batch variability represents a significant impediment to the expansion of the global polyclonal antibodies market. The inherent heterogeneity, arising from their diverse B-cell origins, leads to inconsistencies in product characteristics across different manufacturing lots. This lack of standardization directly affects the reproducibility of diagnostic assays, creating uncertainties in result interpretation and limiting their widespread adoption in both clinical and research environments. For therapeutic applications, inconsistent product profiles complicate dose standardization and can compromise the predictability of patient responses, raising considerable concerns for safety and efficacy.
Key Market Trends
Leveraging recombinant technologies is a pivotal trend transforming the global polyclonal antibodies market by addressing historical challenges in production consistency and scalability. This approach enables more controlled and reproducible manufacturing of antibodies, overcoming the inherent batch-to-batch variability of traditionally derived polyclonal preparations. The advancements in recombinant expression systems facilitate the engineering of specific antibody fragments or pools with defined specificities, enhancing their utility in sensitive applications.
Key Market Players
Thermo Fisher Scientific Inc
Merck KGAA
Abcam Plc
Proteogenex Inc
Proteintech Group, Inc
Bio-Rad Laboratories Inc
BPS Bioscience, Inc
R&D Systems, Inc
Agilent Technologies, Inc.
Cusabio Technology LLC
Report Scope:
In this report, the Global Polyclonal Antibodies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Polyclonal Antibodies Market, By Product:
Primary Antibodies
Secondary Antibodies
Polyclonal Antibodies Market, By Application:
Biomedical Research Diagnostics
Diagnostics
Polyclonal Antibodies Market, By Source:
Rabbits
Goats
Sheep
Mouse
Others
Polyclonal Antibodies Market, By End user:
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Academic & Research Center
Polyclonal Antibodies Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Polyclonal Antibodies Market.
Available Customizations:
Global Polyclonal Antibodies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Polyclonal Antibodies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Primary Antibodies, Secondary Antibodies)
5.2.2. By Application (Biomedical Research Diagnostics, Diagnostics)
5.2.3. By Source (Rabbits, Goats, Sheep, Mouse, Others)
5.2.4. By End user (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Center)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Polyclonal Antibodies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Source
6.2.4. By End user
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Polyclonal Antibodies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Source
6.3.1.2.4. By End user
6.3.2. Canada Polyclonal Antibodies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Source
6.3.2.2.4. By End user
6.3.3. Mexico Polyclonal Antibodies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Source
6.3.3.2.4. By End user
7. Europe Polyclonal Antibodies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Source
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Polyclonal Antibodies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Source
7.3.1.2.4. By End user
7.3.2. France Polyclonal Antibodies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Source
7.3.2.2.4. By End user
7.3.3. United Kingdom Polyclonal Antibodies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Source
7.3.3.2.4. By End user
7.3.4. Italy Polyclonal Antibodies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Source
7.3.4.2.4. By End user
7.3.5. Spain Polyclonal Antibodies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Source
7.3.5.2.4. By End user
8. Asia Pacific Polyclonal Antibodies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Source
8.2.4. By End user
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Polyclonal Antibodies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Source
8.3.1.2.4. By End user
8.3.2. India Polyclonal Antibodies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Source
8.3.2.2.4. By End user
8.3.3. Japan Polyclonal Antibodies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Source
8.3.3.2.4. By End user
8.3.4. South Korea Polyclonal Antibodies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Source
8.3.4.2.4. By End user
8.3.5. Australia Polyclonal Antibodies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Source
8.3.5.2.4. By End user
9. Middle East & Africa Polyclonal Antibodies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Source
9.2.4. By End user
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Polyclonal Antibodies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Source
9.3.1.2.4. By End user
9.3.2. UAE Polyclonal Antibodies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Source
9.3.2.2.4. By End user
9.3.3. South Africa Polyclonal Antibodies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Source
9.3.3.2.4. By End user
10. South America Polyclonal Antibodies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Source
10.2.4. By End user
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Polyclonal Antibodies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Source
10.3.1.2.4. By End user
10.3.2. Colombia Polyclonal Antibodies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Source
10.3.2.2.4. By End user
10.3.3. Argentina Polyclonal Antibodies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Source
10.3.3.2.4. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Polyclonal Antibodies Market: SWOT Analysis
